Table of Contents 1 Study Coverage 1.1 Active Pharma Ingredient Product 1.2 Key Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Active Pharma Ingredient Market Size Growth Rate by Type 1.4.2 Innovative Active Pharmaceutical Ingredients 1.4.3 Generic Active Pharmaceutical Ingredients 1.5 Market by Application 1.5.1 Global Active Pharma Ingredient Market Size Growth Rate by Application 1.5.2 Oncology 1.5.3 Cardiovascular Disease 1.5.4 Diabetes 1.5.5 Central Nervous System and Neurological Disorders 1.5.6 Endocrinology 1.5.7 Other Therapeutic Applications 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Active Pharma Ingredient Market Size 2.1.1 Global Active Pharma Ingredient Revenue 2016-2025 2.1.2 Global Active Pharma Ingredient Sales 2016-2025 2.2 Active Pharma Ingredient Growth Rate by Regions 2.2.1 Global Active Pharma Ingredient Sales by Regions 2.2.2 Global Active Pharma Ingredient Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Active Pharma Ingredient Sales by Manufacturers 3.1.1 Active Pharma Ingredient Sales by Manufacturers 3.1.2 Active Pharma Ingredient Sales Market Share by Manufacturers 3.1.3 Global Active Pharma Ingredient Market Concentration Ratio (CR5 and HHI) 3.2 Active Pharma Ingredient Revenue by Manufacturers 3.2.1 Active Pharma Ingredient Revenue by Manufacturers (2016-2018) 3.2.2 Active Pharma Ingredient Revenue Share by Manufacturers (2016-2018) 3.3 Active Pharma Ingredient Price by Manufacturers 3.4 Active Pharma Ingredient Manufacturing Base Distribution, Product Types 3.4.1 Active Pharma Ingredient Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Active Pharma Ingredient Product Category 3.4.3 Date of International Manufacturers Enter into Active Pharma Ingredient Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type 4.1 Global Active Pharma Ingredient Sales by Type 4.2 Global Active Pharma Ingredient Revenue by Type 4.3 Active Pharma Ingredient Price by Type 5 Breakdown Data by Application 5.1 Overview 5.2 Global Active Pharma Ingredient Breakdown Data by Application 6 North America 6.1 North America Active Pharma Ingredient by Countries 6.1.1 North America Active Pharma Ingredient Sales by Countries 6.1.2 North America Active Pharma Ingredient Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Active Pharma Ingredient by Type 6.3 North America Active Pharma Ingredient by Application 6.4 North America Active Pharma Ingredient by Company 7 Europe 7.1 Europe Active Pharma Ingredient by Countries 7.1.1 Europe Active Pharma Ingredient Sales by Countries 7.1.2 Europe Active Pharma Ingredient Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Active Pharma Ingredient by Type 7.3 Europe Active Pharma Ingredient by Application 7.4 Europe Active Pharma Ingredient by Company 8 Asia Pacific 8.1 Asia Pacific Active Pharma Ingredient by Countries 8.1.1 Asia Pacific Active Pharma Ingredient Sales by Countries 8.1.2 Asia Pacific Active Pharma Ingredient Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Active Pharma Ingredient by Type 8.3 Asia Pacific Active Pharma Ingredient by Application 8.4 Asia Pacific Active Pharma Ingredient by Company 9 Central & South America 9.1 Central & South America Active Pharma Ingredient by Countries 9.1.1 Central & South America Active Pharma Ingredient Sales by Countries 9.1.2 Central & South America Active Pharma Ingredient Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Active Pharma Ingredient by Type 9.3 Central & South America Active Pharma Ingredient by Application 9.4 Central & South America Active Pharma Ingredient by Company 10 Middle East and Africa 10.1 Middle East and Africa Active Pharma Ingredient by Countries 10.1.1 Middle East and Africa Active Pharma Ingredient Sales by Countries 10.1.2 Middle East and Africa Active Pharma Ingredient Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Active Pharma Ingredient by Type 10.3 Middle East and Africa Active Pharma Ingredient by Application 10.4 Middle East and Africa Active Pharma Ingredient by Company 11 Company Profiles 11.1 Teva 11.1.1 Teva Company Details 11.1.2 Company Description 11.1.3 Sales, Revenue and Gross Margin of Active Pharma Ingredient 11.1.4 Active Pharma Ingredient Product Description 11.1.5 Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Company Description 11.2.3 Sales, Revenue and Gross Margin of Active Pharma Ingredient 11.2.4 Active Pharma Ingredient Product Description 11.2.5 Recent Development 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Company Description 11.3.3 Sales, Revenue and Gross Margin of Active Pharma Ingredient 11.3.4 Active Pharma Ingredient Product Description 11.3.5 Recent Development 11.4 Johnson & Johnson 11.4.1 Johnson & Johnson Company Details 11.4.2 Company Description 11.4.3 Sales, Revenue and Gross Margin of Active Pharma Ingredient 11.4.4 Active Pharma Ingredient Product Description 11.4.5 Recent Development 11.5 Mylan 11.5.1 Mylan Company Details 11.5.2 Company Description 11.5.3 Sales, Revenue and Gross Margin of Active Pharma Ingredient 11.5.4 Active Pharma Ingredient Product Description 11.5.5 Recent Development 11.6 North China Pharmaceutical Group 11.6.1 North China Pharmaceutical Group Company Details 11.6.2 Company Description 11.6.3 Sales, Revenue and Gross Margin of Active Pharma Ingredient 11.6.4 Active Pharma Ingredient Product Description 11.6.5 Recent Development 11.7 Dr. Reddy’s Laboratories 11.7.1 Dr. Reddy’s Laboratories Company Details 11.7.2 Company Description 11.7.3 Sales, Revenue and Gross Margin of Active Pharma Ingredient 11.7.4 Active Pharma Ingredient Product Description 11.7.5 Recent Development 11.8 Roche 11.8.1 Roche Company Details 11.8.2 Company Description 11.8.3 Sales, Revenue and Gross Margin of Active Pharma Ingredient 11.8.4 Active Pharma Ingredient Product Description 11.8.5 Recent Development 11.9 Aurobindo pharma 11.9.1 Aurobindo pharma Company Details 11.9.2 Company Description 11.9.3 Sales, Revenue and Gross Margin of Active Pharma Ingredient 11.9.4 Active Pharma Ingredient Product Description 11.9.5 Recent Development 11.10 Sun Pharmaceutical Industries 11.10.1 Sun Pharmaceutical Industries Company Details 11.10.2 Company Description 11.10.3 Sales, Revenue and Gross Margin of Active Pharma Ingredient 11.10.4 Active Pharma Ingredient Product Description 11.10.5 Recent Development 11.11 Boehringer Ingelheim GmbH 11.12 Bayer 11.13 BASF 11.14 DSM 11.15 Zhejiang Medicine 11.16 Biocon 11.17 Johnson Matthey 11.18 Hisun Pharmacy 11.19 Cambrex 11.20 Shandong Xinhua Pharmaceutical 11.21 Lonza group 11.22 Huahai Pharmaceutical 11.23 Haerbin Pharmaceutical Group 11.24 Cipla 11.25 Tian Yao 11.26 Lupin 11.27 North East Pharmaceutical 11.28 Albemarle 11.29 Shandong Lukang Pharmaceutical 11.30 Jiangsu Hengrui Medicine 12 Market Opportunities, Challenges, Risks and Influences Factors Analysis 12.1 Market Opportunities and Drivers 12.2 Market Challenges 12.3 Market Risks/Restraints 12.4 Key World Economic Indicators 13 Value Chain and Sales Channels Analysis 13.1 Value Chain Analysis 13.1.1 Typical Suppliers of Key Active Pharma Ingredient Raw Material 13.1.2 Active Pharma Ingredient Customers 13.2 Sales Channels Analysis 13.2.1 Sales Channels Analysis 13.2.2 Distributors 14 Research Findings and Conclusion 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Author Details 15.3 Disclaimer

List of Tables and Figures Figure Picture of Active Pharma Ingredient Figure Global Active Pharma Ingredient Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025) Figure Global Active Pharma Ingredient Production Market Share by Types (Product Category) in 2017 Figure Innovative Active Pharmaceutical Ingredients Product Picture Table Major Manufacturers of Innovative Active Pharmaceutical Ingredients Figure Generic Active Pharmaceutical Ingredients Product Picture Table Major Manufacturers of Generic Active Pharmaceutical Ingredients Table Global Active Pharma Ingredient Market Size Growth Rate by Application 2018-2025 (K Units) Figure Oncology Figure Cardiovascular Disease Figure Diabetes Figure Central Nervous System and Neurological Disorders Figure Endocrinology Figure Other Therapeutic Applications Figure Active Pharma Ingredient Report Years Considered Figure Global Active Pharma Ingredient Market Size 2016-2025 (Million US$) Figure Global Active Pharma Ingredient Sales 2016-2025 (K Units) Table Global Active Pharma Ingredient Market Size by Regions 2016-2025 (K Units) & (Million US$) Table Global Active Pharma Ingredient Sales by Regions 2016-2025 (K Units) Table Global Active Pharma Ingredient Sales Market Share by Regions 2016-2025 Figure Global Active Pharma Ingredient Sales Market Share by Regions 2016-2025 Figure 2017 Global Active Pharma Ingredient Sales Market Share by Regions Table Global Active Pharma Ingredient Revenue by Regions 2016-2025 (Million US$) Table Global Active Pharma Ingredient Revenue Market Share by Regions 2016-2025 Figure Global Active Pharma Ingredient Revenue Market Share by Regions 2016-2025 Figure 2017 Global Active Pharma Ingredient Revenue Market Share by Regions Table Global Active Pharma Ingredient Sales by Manufacturers (2016-2018) (K Units) Table Global Active Pharma Ingredient Sales Share by Manufacturers (2016-2018) Figure Global Active Pharma Ingredient Sales Share by Manufacturers in 2017 Table Active Pharma Ingredient Revenue by Manufacturers (2016-2018) (Million US$) Table Active Pharma Ingredient Revenue Share by Manufacturers (2016-2018) Figure Active Pharma Ingredient Value Share by Manufacturers in 2017 Table Global Active Pharma Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Manufacturers Active Pharma Ingredient Price (2016-2018) (USD/Unit) Table Active Pharma Ingredient Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Active Pharma Ingredient Product Category Table Date of International Manufacturers Enter into Active Pharma Ingredient Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Active Pharma Ingredient Sales by Type (2016-2025) (K Units) Table Global Active Pharma Ingredient Sales Share by Type (2016-2025) Figure Global Active Pharma Ingredient Sales Market Share by Type (2016-2025) Figure Global Active Pharma Ingredient Sales Market Share by Type in 2017 Table Global Active Pharma Ingredient Revenue by Type (2016-2025) (Million US$) Table Global Active Pharma Ingredient Revenue Share by Type (2016-2025) Figure Global Active Pharma Ingredient Revenue Market Share by Type (2016-2025) Figure Global Active Pharma Ingredient Revenue Market Share by Type in 2017 Table Active Pharma Ingredient Price by Type 2013-2018 (USD/Unit) Table Global Active Pharma Ingredient Sales by Application (2016-2025) (K Units) Table Global Active Pharma Ingredient Sales Share by Application (2016-2025) Figure Global Sales Active Pharma Ingredient Market Share by Application (2016-2025) Figure Global Sales Active Pharma Ingredient Market Share by Application (2016-2025) Figure North America Active Pharma Ingredient Sales Growth Rate 2016-2025 (K Units) Figure North America Active Pharma Ingredient Revenue Growth Rate 2016-2025 (Million US$) Table North America Active Pharma Ingredient Sales by Countries (2016-2025) (K Units) Table North America Active Pharma Ingredient Sales Market Share by Countries (2016-2025) Figure 2017 North America Active Pharma Ingredient Sales Market Share by Countries Table North America Active Pharma Ingredient Revenue by Countries (2016-2025) (Million US$) Table North America Active Pharma Ingredient Revenue Market Share by Countries (2016-2025) Figure 2017 North America Active Pharma Ingredient Revenue Market Share by Countries Figure United States Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure United States Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Figure Canada Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure Canada Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Figure Mexico Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure Mexico Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Table North America Active Pharma Ingredient Sales by Type (2016-2025) (K Units) Table North America Active Pharma Ingredient Sales Market Share by Type (2016-2025) Figure 2017 North America Active Pharma Ingredient Market Share by Type Table North America Active Pharma Ingredient Sales by Application (2016-2025) (K Units) Table North America Active Pharma Ingredient Sales Market Share by Application (2016-2025) Figure 2017 North America Active Pharma Ingredient Market Share by Application Table North America Active Pharma Ingredient Sales by Company (2016-2018) (K Units) Table North America Active Pharma Ingredient Sales Market Share by Company (2016-2018) Figure North America Active Pharma Ingredient Sales Market Share by Company in 2017 Figure Europe Active Pharma Ingredient Sales Growth Rate 2016-2025 (K Units) Figure Europe Active Pharma Ingredient Revenue Growth Rate 2016-2025 (Million US$) Table Europe Active Pharma Ingredient Sales by Countries (2016-2025) (K Units) Table Europe Active Pharma Ingredient Sales Market Share by Countries (2016-2025) Figure 2017 Europe Active Pharma Ingredient Sales Market Share by Countries Table Europe Active Pharma Ingredient Revenue by Countries (2016-2025) (Million US$) Table Europe Active Pharma Ingredient Revenue Market Share by Countries (2016-2025) Figure 2017 Europe Active Pharma Ingredient Revenue Market Share by Countries Figure Germany Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure Germany Active Pharma Ingredient Revenue Growth Rate (2016-2025) (K Units) Figure France Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure France Active Pharma Ingredient Revenue Growth Rate (2016-2025) (K Units) Figure UK Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure UK Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Figure Italy Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure Italy Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Figure Russia Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure Russia Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Table Europe Active Pharma Ingredient Sales by Type (2016-2025) (K Units) Table Europe Active Pharma Ingredient Sales Market Share by Type (2016-2025) Figure 2017 Europe Active Pharma Ingredient Market Share by Type Table Europe Active Pharma Ingredient Sales by Application (2016-2025) (K Units) Table Europe Active Pharma Ingredient Sales Market Share by Application (2016-2025) Figure 2017 Europe Active Pharma Ingredient Market Share by Application Table Europe Active Pharma Ingredient Sales by Company (2016-2018) (K Units) Table Europe Active Pharma Ingredient Sales Market Share by Company (2016-2018) Figure Europe Active Pharma Ingredient Sales Market Share by Company in 2017 Figure Asia Pacific Active Pharma Ingredient Sales Growth Rate 2016-2025 (K Units) Figure Asia Pacific Active Pharma Ingredient Revenue Growth Rate 2016-2025 (Million US$) Table Asia Pacific Active Pharma Ingredient Sales by Countries (2016-2025) (K Units) Table Asia Pacific Active Pharma Ingredient Sales Market Share by Countries (2016-2025) Figure 2017 Asia Pacific Active Pharma Ingredient Sales Market Share by Countries Table Asia Pacific Active Pharma Ingredient Revenue by Countries (2016-2025) (Million US$) Table Asia Pacific Active Pharma Ingredient Revenue Market Share by Countries (2016-2025) Figure 2017 Asia Pacific Active Pharma Ingredient Revenue Market Share by Countries Figure China Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure China Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Figure Japan Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure Japan Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Figure Korea Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure Korea Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Figure India Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure India Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Figure Australia Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure Australia Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Figure Indonesia Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure Indonesia Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Figure Malaysia Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure Malaysia Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Figure Philippines Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure Philippines Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Figure Thailand Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure Thailand Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Figure Vietnam Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure Vietnam Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Figure Singapore Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure Singapore Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Table Asia Pacific Active Pharma Ingredient Sales by Type (2016-2025) (K Units) Table Asia Pacific Active Pharma Ingredient Sales Market Share by Type (2016-2025) Figure 2017 Asia Pacific Active Pharma Ingredient Market Share by Type Table Asia Pacific Active Pharma Ingredient Sales by Application (2016-2025) (K Units) Table Asia Pacific Active Pharma Ingredient Sales Market Share by Application (2016-2025) Figure 2017 Asia Pacific Active Pharma Ingredient Market Share by Application Table Asia Pacific Active Pharma Ingredient Sales by Company (2016-2018) (K Units) Table Asia Pacific Active Pharma Ingredient Sales Market Share by Company (2016-2018) Figure Asia Pacific Active Pharma Ingredient Sales Market Share by Company in 2017 Figure Central & South America Active Pharma Ingredient Sales Growth Rate 2016-2025 (K Units) Figure Central & South America Active Pharma Ingredient Revenue Growth Rate 2016-2025 (Million US$) Table Central & South America Active Pharma Ingredient Sales by Countries (2016-2025) (K Units) Table Central & South America Active Pharma Ingredient Sales Market Share by Countries (2016-2025) Figure 2017 Central & South America Active Pharma Ingredient Sales Market Share by Countries Table Central & South America Active Pharma Ingredient Revenue by Countries (2016-2025) (Million US$) Table Central & South America Active Pharma Ingredient Revenue Market Share by Countries (2016-2025) Figure 2017 Central & South America Active Pharma Ingredient Revenue Market Share by Countries Figure Brazil Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure Brazil Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Figure Argentina Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure Argentina Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Table Central & South America Active Pharma Ingredient Sales by Type (2016-2025) (K Units) Table Central & South America Active Pharma Ingredient Sales Market Share by Type (2016-2025) Figure 2017 Central & South America Active Pharma Ingredient Market Share by Type Table Central & South America Active Pharma Ingredient Sales by Application (2016-2025) (K Units) Table Central & South America Active Pharma Ingredient Sales Market Share by Application (2016-2025) Figure 2017 Central & South America Active Pharma Ingredient Market Share by Application Table Central & South America Active Pharma Ingredient Sales by Company (2016-2018) (K Units) Table Central & South America Active Pharma Ingredient Sales Market Share by Company (2016-2018) Figure Central & South America Active Pharma Ingredient Sales Market Share by Company in 2017 Figure Middle East and Africa Active Pharma Ingredient Sales Growth Rate 2016-2025 (K Units) Figure Middle East and Africa Active Pharma Ingredient Revenue Growth Rate 2016-2025 (Million US$) Table Middle East and Africa Active Pharma Ingredient Sales by Countries (2016-2025) (K Units) Table Middle East and Africa Active Pharma Ingredient Sales Market Share by Countries (2016-2025) Figure 2017 Middle East and Africa Active Pharma Ingredient Sales Market Share by Countries Table Middle East and Africa Active Pharma Ingredient Revenue by Countries (2016-2025) (Million US$) Table Middle East and Africa Active Pharma Ingredient Revenue Market Share by Countries (2016-2025) Figure 2017 Middle East and Africa Active Pharma Ingredient Revenue Market Share by Countries Figure GCC Countries Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure GCC Countries Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Figure Turkey Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure Turkey Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Figure Egypt Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure Egypt Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Figure South Africa Active Pharma Ingredient Sales Growth Rate (2016-2025) (K Units) Figure South Africa Active Pharma Ingredient Revenue Growth Rate (2016-2025) (Million US$) Table Middle East and Africa Active Pharma Ingredient Sales by Type (2016-2025) (K Units) Table Middle East and Africa Active Pharma Ingredient Sales Market Share by Type (2016-2025) Figure 2017 Middle East and Africa Active Pharma Ingredient Market Share by Type Table Middle East and Africa Active Pharma Ingredient Sales by Application (2016-2025) (K Units) Table Middle East and Africa Active Pharma Ingredient Sales Market Share by Application (2016-2025) Figure 2017 Middle East and Africa Active Pharma Ingredient Market Share by Application Table Middle East and Africa Active Pharma Ingredient Sales by Company (2016-2018) (K Units) Table Middle East and Africa Active Pharma Ingredient Sales Market Share by Company (2016-2018) Figure Middle East and Africa Active Pharma Ingredient Sales Market Share by Company in 2017 Table Teva Company Details Table Teva Active Pharma Ingredient Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Teva Recent Development Table Novartis Company Details Table Novartis Active Pharma Ingredient Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Novartis Recent Development Table Pfizer Company Details Table Pfizer Active Pharma Ingredient Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Pfizer Recent Development Table Johnson & Johnson Company Details Table Johnson & Johnson Active Pharma Ingredient Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Johnson & Johnson Recent Development Table Mylan Company Details Table Mylan Active Pharma Ingredient Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Mylan Recent Development Table North China Pharmaceutical Group Company Details Table North China Pharmaceutical Group Active Pharma Ingredient Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table North China Pharmaceutical Group Recent Development Table Dr. Reddy’s Laboratories Company Details Table Dr. Reddy’s Laboratories Active Pharma Ingredient Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Dr. Reddy’s Laboratories Recent Development Table Roche Company Details Table Roche Active Pharma Ingredient Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Roche Recent Development Table Aurobindo pharma Company Details Table Aurobindo pharma Active Pharma Ingredient Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Aurobindo pharma Recent Development Table Sun Pharmaceutical Industries Company Details Table Sun Pharmaceutical Industries Active Pharma Ingredient Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Sun Pharmaceutical Industries Recent Development Table Boehringer Ingelheim GmbH Company Details Table Bayer Company Details Table BASF Company Details Table DSM Company Details Table Zhejiang Medicine Company Details Table Biocon Company Details Table Johnson Matthey Company Details Table Hisun Pharmacy Company Details Table Cambrex Company Details Table Shandong Xinhua Pharmaceutical Company Details Table Lonza group Company Details Table Huahai Pharmaceutical Company Details Table Haerbin Pharmaceutical Group Company Details Table Cipla Company Details Table Tian Yao Company Details Table Lupin Company Details Table North East Pharmaceutical Company Details Table Albemarle Company Details Table Shandong Lukang Pharmaceutical Company Details Table Jiangsu Hengrui Medicine Company Details Figure GDP by Regions / Largest Economies Pie Chart in 2016 Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060 Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016 Figure Saving Rate Total, % of GDP, 2015 Table Active Pharma Ingredient Value Chain Table Typical Suppliers of Key Active Pharma Ingredient Raw Material Table Active Pharma Ingredient Customers List Table Active Pharma Ingredient Sales Channels Table Active Pharma Ingredient Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources